IGFBP3 and endometrial cancer: We present here results of a population-based case–control study in Sweden, in which we assessed the relationships of endometrial cancer risk with serum levels of fasting insulin, IGF-I, and IGFBP-1, as well as IGFBP-3, IGF's major binding protein in the circulation.